Estriol

Cream

1 mg/gm  |  2 mg/gm

Ready to prescribe?
Disclaimer: Images are for reference only; actual products may vary.

Product Overview Coming Soon

Product Overview

Estriol Cream Description1-5

Micronized estriol is a bioidentical form of estriol (E3), one of the three naturally occurring estrogens in women, alongside estradiol and estrone. Estriol is the weakest of the estrogens, with lower receptor binding affinity and a shorter duration of action compared to estradiol (E2). Despite being the weakest estrogen, estriol may support skin rejuvenation, including restoration of dermal thickness and elasticity. It is most commonly used alongside estradiol in postmenopausal women with estrogen deficiency and is typically formulated in a transdermal cream to allow for incremental dosing adjustments.

References

1. Cynthia A. Stuenkel, Susan R. Davis, Anne Gompel, Mary Ann Lumsden, M. Hassan Murad, JoAnn V. Pinkerton, Richard J. Santen, Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 100, Issue 11, 1 November 2015, Pages 3975–4011, accessed July 2025 through: https://doi.org/10.1210/jc.2015-2236

2.North American Menopause Society (NAMS) Position Statement on Hormone Therapy (2022) Supports vaginal estrogen (including estriol) for GSM with minimal systemic risks; accessed July 2025 through: https://www.menopause.org/docs/default-source/professional/2022-nams-ht-position-statement.pdf

3. NIH DailyMed, Estriol; accessed July 2025 though:  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=estriol

4. Estriol: A Comprehensive Guide for Patients; accessed July 2025 through: https://clinicaltrials.eu/inn/estriol/

5. Rzepecki AK, Murase JE, Juran R, Fabi SG, McLellan BN. Estrogen-deficient skin: The role of topical therapy. Int J Womens Dermatol. 2019 Mar 15;5(2):85-90. Accessed July 2025; doi: 10.1016/j.ijwd.2019.01.001. PMID: 30997378; PMCID: PMC6451761

Mechanism of Action1-5

Estriol acts by binding to estrogen receptors alpha (ERα) and beta (ERβ) in estrogen-responsive tissues, particularly the vaginal epithelium, bladder, urethra, and pelvic floor musculature.

Mechanisms and Effects

  • Can help restore vaginal epithelial thickness and improves cell maturation index
  • Can improve blood flow, elasticity, and lubrication of vaginal tissues
  • Locally can improve thickening of dermal-epidermal junction, potentially improving skin firmness
  • May exert cytoprotective and anti-inflammatory effects on urogenital tissues

Common1-5

  • Transient burning, itching, or discharge
  • Spotting or light bleeding (usually resolves quickly)
  • Increased vaginal secretions

Systemic (rare at low doses)1-5

  • Breast tenderness
  • Headache
  • Nausea
  • Edema

Contraindications1-5

  • Active or history of estrogen-dependent cancers (e.g., breast, endometrial) — unless use is explicitly approved by an oncology or menopause specialist
  • Active or recent thromboembolic disease
  • Undiagnosed abnormal genital bleeding
  • Severe liver dysfunction
  • Hypersensitivity to estriol or excipients

Precautions1-5

Use caution in:

  • Women with a history of estrogen-sensitive malignancy
  • Liver disease
  • Migraines with aura
  • Uncontrolled hypertension

Store in a cool, dry place, away from direct light and heat; Room temperature (20°C–25°C / 68°F–77°F) is ideal. Keep out of reach of children and pets.

1. Cynthia A. Stuenkel, Susan R. Davis, Anne Gompel, Mary Ann Lumsden, M. Hassan Murad, JoAnn V. Pinkerton, Richard J. Santen, Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 100, Issue 11, 1 November 2015, Pages 3975–4011, accessed July 2025 through: https://doi.org/10.1210/jc.2015-2236

2.North American Menopause Society (NAMS) Position Statement on Hormone Therapy (2022) Supports vaginal estrogen (including estriol) for GSM with minimal systemic risks; accessed July 2025 through: https://www.menopause.org/docs/default-source/professional/2022-nams-ht-position-statement.pdf

3. NIH DailyMed, Estriol; accessed July 2025 though:  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=estriol

4. Estriol: A Comprehensive Guide for Patients; accessed July 2025 through: https://clinicaltrials.eu/inn/estriol/

5. Rzepecki AK, Murase JE, Juran R, Fabi SG, McLellan BN. Estrogen-deficient skin: The role of topical therapy. Int J Womens Dermatol. 2019 Mar 15;5(2):85-90. Accessed July 2025; doi: 10.1016/j.ijwd.2019.01.001. PMID: 30997378; PMCID: PMC6451761

This information is for educational purposes only.
This compounded product has not been reviewed, approved, or evaluated by the Food and Drug Administration for safety and effectiveness. This product is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding treatment, cure, or prevention of any disease or condition.
This information is a summary. It may not cover all possible drug information about this product. For complete product information, refer to the manufacturer’s prescribing information and labeling. Call your doctor for medical advice and/or about side effects. You may report side effects to the FDA at 1-800-FDA-1088. A WP Pharma Labs pharmacist will be happy to answer any questions. For consultation, please call 1-800-441-0048.

EXPLORE MORE

Related Medications

Licensed to ship across the U.S.

Your orders arrive promptly and privately, delivered directly to your door.

Providers: Let’s Partner for Better Patient Care

If you are a physician, clinic, or practice seeking a dependable Compounding Pharmacy partner, WP Pharma Labs is here to help. With dedicated account setup, streamlined ordering and responsive service, we support your therapeutic goals with specialized compounds designed for your patients.

To check product availability, check on the status of an existing order, request refills:
orders@wppharmalabs.com

New providers setup / update an existing account:
newaccounts@wppharmalabs.com